Eversept Partners, LP
- SEC CIK
- 0001697013
- Latest filing
- Aug 14, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 14, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 115
- +11 vs. Q1 2026
- Portfolio value
- $1.83B
- +$316.9M (+20.9%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| AVTXAvalo Therapeutics, Inc. | COM NEW | 10,000 | $184.8K | <0.1% | +10,000 | New | History |
| GHRSGH Research PLC | ORDINARY SHARES | 8,672 | $233.1K | <0.1% | +8,672 | New | History |
| SLQTSelectQuote, Inc. | COM | 319,788 | $269.0K | <0.1% | −37,873−10.6% | Reduced | History |
| RVPRetractable Technologies Inc | COM | 580,919 | $418.3K | <0.1% | 00.0% | Unchanged | History |
| ASMBAssembly Biosciences, Inc. | COM NEW | 16,510 | $453.7K | <0.1% | −24,379−59.6% | Reduced | History |
| SSIISS Innovations International, Inc. | COM NEW | 110,157 | $457.2K | <0.1% | 00.0% | Unchanged | History |
| AKBAAkebia Therapeutics, Inc. | COM | 427,095 | $486.9K | <0.1% | +427,095 | New | History |
| ATAIAtaiBeckley Inc. | COM SHS | 102,430 | $539.8K | <0.1% | +102,430 | New | History |
| EHTHeHealth, Inc. | COM | 404,854 | $603.2K | <0.1% | +183,939+83.3% | Added | History |
| RLMDRelmada Therapeutics, Inc. | COM | 93,192 | $644.9K | <0.1% | −184,707−66.5% | Reduced | History |
| LPCNLipocine Inc. | COM NEW | 294,989 | $755.2K | <0.1% | 00.0% | Unchanged | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 190,715 | $808.6K | <0.1% | 00.0% | Unchanged | History |
| ENGNenGene Therapeutics Inc. | COM | 469,584 | $812.4K | <0.1% | −40,959−8.0% | Reduced | History |
| ODTXOdyssey Therapeutics, Inc. | COMMON STOCK | 49,658 | $929.1K | 0.1% | +49,658 | New | History |
| HELPHelus Pharma Inc. | COM NEW | 146,403 | $967.7K | 0.1% | +146,403 | New | History |
| PLRXPliant Therapeutics, Inc. | COM | 891,425 | $1.02M | 0.1% | 00.0% | Unchanged | History |
| INOInovio Pharmaceuticals, Inc. | COM SHS | 1,035,360 | $1.14M | 0.1% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM NEW | 47,777 | $1.24M | 0.1% | −10,847−18.5% | Reduced | History |
| SVRASavara Inc | COM | 204,428 | $1.26M | 0.1% | −179,836−46.8% | Reduced | History |
| RVMDRevolution Medicines, Inc. | COM | 6,943 | $1.30M | 0.1% | +6,943 | New | History |
| TECHBIO-TECHNE Corp | COM | 19,308 | $1.36M | 0.1% | −106,588−84.7% | Reduced | History |
| WHWKWhitehawk Therapeutics, Inc. | COM | 303,306 | $1.39M | 0.1% | −3,494−1.1% | Reduced | History |
| EDITEditas Medicine, Inc. | COM | 458,809 | $1.49M | 0.1% | +167,890+57.7% | Added | History |
| VIRVir Biotechnology, Inc. | COM | 156,636 | $1.60M | 0.1% | −93,364−37.3% | Reduced | History |
| AVRAnteris Technologies Global Corp. | COM | 166,229 | $1.64M | 0.1% | −234,958−58.6% | Reduced | History |
| GRCEGrace Therapeutics, Inc. | CL A | 772,900 | $1.75M | 0.1% | +16,300+2.2% | Added | History |
| PRQRProQR Therapeutics N.V. | SHS EURO | 1,022,265 | $1.90M | 0.1% | +1,022,265 | New | History |
| IVVDInvivyd, Inc. | COM | 2,237,015 | $1.95M | 0.1% | −39,334−1.7% | Reduced | History |
| RGENRepligen Corp | COM | 14,401 | $1.96M | 0.1% | −106,384−88.1% | Reduced | History |
| SPRBSpruce Biosciences, Inc. | COM NEW | 40,000 | $2.16M | 0.1% | +40,000 | New | History |
| AMRNAmarin Corp PLC | SPONSORED ADR | 145,296 | $2.32M | 0.1% | −2,419−1.6% | Reduced | History |
| EVMNEvommune, Inc. | COM SHS | 174,460 | $2.32M | 0.1% | +119,780+219.1% | Added | History |
| CTNMContineum Therapeutics, Inc. | CL A | 148,017 | $2.43M | 0.1% | +1,606+1.1% | Added | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 1,890,904 | $2.53M | 0.1% | −457,456−19.5% | Reduced | History |
| KPTIKaryopharm Therapeutics Inc. | COM NEW | 276,174 | $2.70M | 0.1% | 00.0% | Unchanged | History |
| DSGNDesign Therapeutics, Inc. | COM | 190,000 | $2.75M | 0.1% | +190,000 | New | History |
| VORVor Biopharma Inc. | COM NEW | 149,681 | $2.76M | 0.2% | +149,681 | New | History |
| ALECAlector, Inc. | COM | 1,423,873 | $2.86M | 0.2% | +72,767+5.4% | Added | History |
| ISRGIntuitive Surgical Inc | COM NEW | 7,241 | $2.88M | 0.2% | −3,878−34.9% | Reduced | History |
| IFRXInflaRx N.V. | COM | 1,304,069 | $2.92M | 0.2% | −454,504−25.8% | Reduced | History |
| SPRYARS Pharmaceuticals, Inc. | COM | 377,007 | $3.02M | 0.2% | +240,772+176.7% | Added | History |
| ANROAlto Neuroscience, Inc. | COM SHS | 128,286 | $3.39M | 0.2% | +3,118+2.5% | Added | History |
| TARSTarsus Pharmaceuticals, Inc. | COM | 55,710 | $3.51M | 0.2% | +55,710 | New | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 135,355 | $3.55M | 0.2% | −441,225−76.5% | Reduced | History |
| AGLagilon health, inc. | COM NEW | 37,792 | $4.05M | 0.2% | −138,796−78.6% | Reduced | History |
| GKOSGLAUKOS Corp | COM | 29,343 | $4.10M | 0.2% | −30,871−51.3% | Reduced | History |
| SNDASonida Senior Living, Inc. | COM | 102,624 | $4.19M | 0.2% | +74,187+260.9% | Added | History |
| EYPTEyePoint, Inc. | COM NEW | 297,735 | $4.26M | 0.2% | +297,735 | New | History |
| NHCNational Healthcare Corp | COM | 22,116 | $4.67M | 0.3% | +22,116 | New | History |
| ANABAnaptysbio, Inc | COM | 69,983 | $4.72M | 0.3% | +42,894+158.3% | Added | History |
| EQEquillium, Inc. | COM | 1,520,824 | $4.87M | 0.3% | +21,831+1.5% | Added | History |
| PACSPACS Group, Inc. | COM SHS | 117,441 | $5.01M | 0.3% | +117,441 | New | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 154,130 | $5.15M | 0.3% | +91,555+146.3% | Added | History |
| NHINational Health Investors Inc | COM | 70,673 | $5.39M | 0.3% | +70,673 | New | History |
| BEAMBeam Therapeutics Inc. | COM | 166,289 | $5.71M | 0.3% | +166,289 | New | History |
| LBRXLB Pharmaceuticals Inc | COM SHS | 183,663 | $5.96M | 0.3% | +83,465+83.3% | Added | History |
| REPLReplimune Group, Inc. | COM | 590,252 | $6.53M | 0.4% | +255,391+76.3% | Added | History |
| ELVNEnliven Therapeutics, Inc. | COM | 136,631 | $6.93M | 0.4% | +136,631 | New | History |
| PTGXProtagonist Therapeutics, Inc | COM | 58,504 | $7.17M | 0.4% | +58,504 | New | History |
| BHVNBiohaven Ltd. | COM | 515,804 | $7.68M | 0.4% | +515,804 | New | History |
| NVONovo Nordisk A S | ADR | 169,227 | $8.11M | 0.4% | +169,227 | New | History |
| RLAYRelay Therapeutics, Inc. | COM | 434,314 | $8.13M | 0.4% | +163,609+60.4% | Added | History |
| MLYSMineralys Therapeutics, Inc. | COM | 309,689 | $8.36M | 0.5% | +309,689 | New | History |
| ARDXArdelyx, Inc. | COM | 1,678,345 | $8.56M | 0.5% | −551,101−24.7% | Reduced | History |
| PALIPalisade Bio, Inc. | COM | 4,182,785 | $8.74M | 0.5% | −804,714−16.1% | Reduced | History |
| RVTYRevvity, Inc. | COM | 83,624 | $9.30M | 0.5% | −1,230−1.4% | Reduced | History |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 275,471 | $9.34M | 0.5% | −10,293−3.6% | Reduced | History |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 672,825 | $9.52M | 0.5% | −5,099−0.8% | Reduced | History |
| DFTXDefinium Therapeutics, Inc. | COM SHS | 217,185 | $10.2M | 0.6% | +56,462+35.1% | Added | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 196,302 | $10.5M | 0.6% | +58,266+42.2% | Added | History |
| MRNAModerna, Inc. | Stock | 152,122 | $10.7M | 0.6% | −7,586−4.7% | Reduced | History |
| BRKRBruker Corp | COM | 182,894 | $11.0M | 0.6% | +65,881+56.3% | Added | History |
| ASNDAscendis Pharma A/S | ORD SHS | 41,621 | $11.1M | 0.6% | +41,621 | New | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 747,994 | $11.2M | 0.6% | +747,994 | New | History |
| XENEXenon Pharmaceuticals Inc. | COM | 196,532 | $11.9M | 0.6% | +66,958+51.7% | Added | History |
| HUMHumana Inc | Stock | 31,171 | $12.4M | 0.7% | +31,171 | New | History |
| CTMXCytomX Therapeutics, Inc. | COM | 3,558,497 | $13.3M | 0.7% | +369,983+11.6% | Added | History |
| PHVSPharvaris N.V. | COM | 386,383 | $13.4M | 0.7% | −20,577−5.1% | Reduced | History |
| CELCCelcuity Inc. | COM | 127,931 | $13.4M | 0.7% | +127,931 | New | History |
| AMNAmn Healthcare Services Inc | COM | 428,531 | $13.9M | 0.8% | +428,531 | New | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 249,607 | $14.3M | 0.8% | +41,839+20.1% | Added | History |
| VRDNViridian Therapeutics, Inc. | COM | 831,142 | $15.3M | 0.8% | +117,873+16.5% | Added | History |
| INSMINSMED Inc | COM PAR $.01 | 149,209 | $15.9M | 0.9% | +149,209 | New | History |
| LTCLTC Properties Inc | REIT | 420,640 | $16.2M | 0.9% | +99,594+31.0% | Added | History |
| PNTGPennant Group, Inc. | COM | 460,272 | $17.0M | 0.9% | +148,094+47.4% | Added | History |
| MOHMolina Healthcare, Inc. | COM | 80,594 | $18.4M | 1.0% | +47,783+145.6% | Added | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 1,865,653 | $18.7M | 1.0% | −1,174,167−38.6% | Reduced | History |
| COGTCogent Biosciences, Inc. | COM | 490,235 | $19.0M | 1.0% | +490,235 | New | History |
| BBNXBeta Bionics, Inc. | COM | 1,249,441 | $19.6M | 1.1% | −165,397−11.7% | Reduced | History |
| WELLWelltower Inc. | REIT | 87,312 | $19.8M | 1.1% | −93,641−51.7% | Reduced | History |
| UNHUnitedHealth Group Inc | Stock | 51,145 | $21.3M | 1.2% | +51,145 | New | History |
| THCTenet Healthcare Corp | COM NEW | 114,199 | $21.4M | 1.2% | +84,687+287.0% | Added | History |
| PODDInsulet Corp | Stock | 148,816 | $22.7M | 1.2% | +5,270+3.7% | Added | History |
| OHIOmega Healthcare Investors Inc | COM | 483,547 | $23.1M | 1.3% | −102,133−17.4% | Reduced | History |
| VKTXViking Therapeutics, Inc. | COM | 602,922 | $23.5M | 1.3% | +363,812+152.2% | Added | History |
| GERNGeron Corp | COM | 18,717,422 | $24.0M | 1.3% | −117,461−0.6% | Reduced | History |
| LLYEli Lilly & Co | Stock | 20,116 | $24.1M | 1.3% | +1,116+5.9% | Added | History |
| CHEChemed Corp | COM | 52,523 | $24.5M | 1.3% | +21,466+69.1% | Added | History |
| GSKGSK plc | ADR | 481,833 | $25.3M | 1.4% | −1,303,342−73.0% | Reduced | History |
| CYHCommunity Health Systems Inc | COM | 7,864,575 | $26.3M | 1.4% | −812,706−9.4% | Reduced | History |
Options (5)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q1 2026 (20)
Positions held at the end of Q1 2026 that are gone from this filing.
| Security | Class | Shares in Q1 2026 | Value in Q1 2026 | % of portfolio in Q1 2026 | History |
|---|---|---|---|---|---|
| DOCHealthpeak Properties, Inc. | COM | 1,981,070 | $32.5M | 2.1% | History |
| AVTRAvantor, Inc. | COM | 2,974,287 | $23.3M | 1.5% | History |
| QGENQiagen N.V. | ORD SHARES | 545,330 | $21.8M | 1.4% | History |
| ICLRIcon PLC | COM | 68,688 | $7.60M | 0.5% | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 200,000 | $6.77M | 0.4% | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 10,000 | $5.23M | 0.3% | History |
| ESPREsperion Therapeutics, Inc. | COM | 1,735,963 | $4.76M | 0.3% | History |
| HQYHealthequity, Inc. | COM | 51,614 | $4.31M | 0.3% | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 183,902 | $3.94M | 0.3% | History |
| CNCCentene Corp | Stock | 111,652 | $3.66M | 0.2% | History |
| EHABEnhabit, Inc. | COM | 227,451 | $3.20M | 0.2% | History |
| STROSutro Biopharma, Inc. | COM SHS | 73,161 | $1.82M | 0.1% | History |
| NVCRNovoCure Ltd | ORD SHS | 134,917 | $1.47M | 0.1% | History |
| BVSBioventus Inc. | COM CL A | 159,110 | $1.45M | 0.1% | History |
| IMCRImmunocore Holdings plc | ADS | 39,238 | $1.18M | 0.1% | History |
| TYRATyra Biosciences, Inc. | COM | 27,055 | $1.04M | 0.1% | History |
| PASGPassage BIO, Inc. | COM | 131,581 | $1.03M | 0.1% | History |
| DHCDiversified Healthcare Trust | COM SH BEN INT | 151,283 | $1.00M | 0.1% | History |
| INMDInMode Ltd. | SHS | 67,744 | $926.7K | 0.1% | History |
| AIRSAirsculpt Technologies, Inc. | COM | 74,139 | $209.8K | <0.1% | History |